$15.90▼-0.18 (-1.12%)
After Hours:$15.82-0.08 (-0.50%)
Ultragenyx Pharmaceutical Inc. (RARE)
Operating Cash Flow Growth
1.98%
TTM · Period ending:

RARE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported1.98%period ending
Latest reported1.98%period ending
RARE TTM Cash from Operations YoY % (-57.78% → 1.98%)
Year-over-year change
High-resolution chart · PNG
What is operating cash flow growth?
Year-over-year operating cash flow growth rate.
RARE operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 1.9846% | |
| -15.1944% | |
| -27.335% | |
| -12.5093% | |
| -6.4705% | |
| 10.2716% | |
| 23.3414% | |
| 12.7669% | |
| 13.0194% | |
| -2.3442% | |
| -21.1655% | |
| -24.7962% | |
| -39.7069% | |
| -48.5616% | |
| -41.4124% | |
| -12.3326% | |
| 0.6736% | |
| 11.5576% | |
| -51.145% | |
| -156.1602% | |
| -144.5599% | |
| -107.383% | |
| 43.0288% | |
| 61.7179% | |
| 56.9234% | |
| 45.6682% | |
| -16.1344% | |
| -18.8656% | |
| -3.9999% | |
| -0.1539% | |
| -5.2273% | |
| -14.4668% | |
| -44.0765% | |
| -65.9258% | |
| -59.1313% | |
| -57.6909% | |
| -42.9045% | |
| -19.8316% | |
| -33.0839% | |
| -51.8962% | |
| -91.5226% | |
| -156.3302% | |
| -146.8873% | |
| -137.4356% | |
| -102.3596% | |
| -71.5444% | |
| -62.3109% | |
| -43.0577% | |
| -57.7821% |
Explore More
RARE Financial Metrics
Explore 130+ historical metrics & ratios
Stock Comparison
Compare equities side by side
52-Week Highs Breakout
Stocks breaking to new annual highs
52-Week Lows Oversold
S&P 500 oversold value screener
Trending Momentum
Relative strength momentum leaders
Earnings Calendar
Upcoming earnings dates & reports
S&P 500 Screener
Filter and sort all 500 stocks
Market Movers
Today's biggest gainers and losers
Market Heatmap
Visual sector performance